"Silent hypoxemia" is one of the physiopathological characteristics of COVID-19, may be caused due to the alterations made by the coronavirus, in the ability of the carotid body to detect blood oxygen levels.
Combination of an LSU health-patented drug and selected DHA derivatives - a novel therapeutic strategy, has the potential to protect the brain cells by increasing the recovery after an ischemic stroke.
Computer simulations may add on to the cognitive tests to gauge the presence and severity of behavioral problems in children with attention deficit/hyperactivity disorder (ADHD).
The World Health Organization (WHO) has granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine.
By April 2021, Italy is planning to vaccinate 10 to 15 million of its roughly 60 million citizens against the novel coronavirus, Prime Minister Giuseppe Conte said.
